Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus

Journal of Rheumatology

Volumn 35, Issue 10, 2008, Pages 1989-1993

  Singh, Vandana ^a   Mahoney, James A ^b   Petri, Michelle ^b,c  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Complement; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4D;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETICULOCYTE; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMPLEMENT C4B; ERYTHROCYTES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECEPTORS, COMPLEMENT 3B; SEVERITY OF ILLNESS INDEX;

EID: 54949117146     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
3. Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin N Am 2005;31:245-54.
4. Sinico RA, Bollini B, Sabadini E, Di Toma L, Radice A. The use of laboratory tests in diagnosis and monitoring of systemic lupus erythematosus. J Nephrol 2002;15 Suppl 6:S20-7.
5. Petri M, Watson R, Winkelstein JA, McLean RH. Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine 1993;72:236-44.
6. Manzi S, Ahearn JM, Salmon J. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. Lupus 2004;13:298-303.
7. Manzi S, Navratil JS, Ruffing MJ, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004;50:3596-604.
8. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum 2005;52:3087-99.
9. Petri M, Kim MY, Kalunian KC, et al. OC-SELENA Trial. Combined oral contraceptive in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
10. Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211-20.
11. Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005;52:2120-4.
12. Gomez-Puerta JA, Martin H, Amigo M, et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine 2005;84:225-30.
13. Fischetti F, Durigutto P, Pellis V, et al. Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor. Blood 2005;106:2340-6.
14. Davis WD, Brey RL. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Rheumatol 1992;10:455-60.
15. McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum 2004;50:1226-32.
16. Laskin CA, Clark C, Spitzer K. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts? Rheum Dis Clin N Am 2005;31:255-72.